US2900415A
(en)
|
1954-12-14 |
1959-08-18 |
Lakeside Lab Inc |
Synthesized antispasmodic compounds
|
CH498122A
(de)
|
1968-02-09 |
1970-10-31 |
Geigy Ag J R |
Verfahren zur Herstellung eines neuen Tetrahydroazepinderivates
|
CH481110A
(de)
|
1967-02-17 |
1969-11-15 |
Geigy Ag J R |
Verfahren zur Herstellung von 1,2,4,5-Tetrahydro-3-azepinen
|
CH500194A
(de)
|
1968-02-15 |
1970-12-15 |
Ciba Geigy Ag |
Verfahren zur Herstellung von Tetrahydroazepinderivaten
|
CA974989A
(en)
|
1968-03-11 |
1975-09-23 |
Wallace And Tiernan Inc. |
Process for preparing 1,2,4,5-tetrahydro-3h,3-benzazepines and products obtained thereby
|
US4233217A
(en)
|
1968-03-11 |
1980-11-11 |
Pennwalt Corporation |
Substituted 1,2,4,5-tetrahydro-3H, 3 benzazepines
|
FR314F
(ru)
|
1968-03-22 |
1970-05-25 |
|
|
FR7736M
(ru)
|
1968-09-02 |
1970-03-09 |
|
|
US3716639A
(en)
|
1970-03-11 |
1973-02-13 |
Ciba Geigy Corp |
Anorexigenic tetrahydrobenzazepines
|
US3795683A
(en)
|
1970-08-19 |
1974-03-05 |
Hoffmann La Roche |
2,3,4,5-tetrahydro-1h-3-benzazepines
|
LU65954A1
(ru)
|
1972-08-25 |
1974-03-07 |
|
|
US4210749A
(en)
|
1974-11-12 |
1980-07-01 |
Pennwalt Corporation |
Substituted 1,2,4,5-tetrahydro-3H,3 benzazepines
|
SE7510988L
(sv)
|
1975-10-01 |
1977-04-02 |
Draco Ab |
Nya farmaceutiskt aktiva foreningar
|
DE2627479C2
(de)
|
1976-06-18 |
1983-09-22 |
Bergwerksverband Gmbh, 4300 Essen |
Verwendung eines Formkokses als Adsorptionsmittel für Schwefeloxide aus Abgasen
|
US4111957A
(en)
|
1977-02-02 |
1978-09-05 |
Smithkline Corporation |
Substituted 1-thienyl and furyl-2,3,4,5-tetrahydro-1H-3-benzazepine compounds
|
US4108989A
(en)
|
1977-04-01 |
1978-08-22 |
Smithkline Corporation |
2,3,4,5-tetrahydro-1h-3-benzazepine-7,8-diones
|
DE2758001A1
(de)
|
1977-12-24 |
1979-07-12 |
Hoechst Ag |
Cephalosporinderivate und verfahren zu ihrer herstellung
|
CA1090797A
(en)
|
1978-06-20 |
1980-12-02 |
Kenneth G. Holden |
Substituted 1-thienyl and furyl-2,3,4,5-tetrahydro-1h- 3-benzazepine compounds
|
AU515236B2
(en)
|
1978-06-26 |
1981-03-26 |
Smithkline Corporation |
Substituted-1-thienyl and furyl-2,3,4,5-tetrahydro-14-3 benzazepine derivatives
|
ZA792785B
(en)
|
1978-07-07 |
1980-08-27 |
Smithkline Corp |
Mercapto substituted-2,3,4,5-tetrahydro-1h-3-benzazepines
|
IE50355B1
(en)
|
1979-10-20 |
1986-04-02 |
Wyeth John & Brother Ltd |
Morpholine derivatives
|
US4477378A
(en)
|
1980-02-05 |
1984-10-16 |
Schering Corp. |
Esters of substituted 8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
|
DE3272044D1
(de)
|
1981-11-27 |
1986-08-21 |
Smithkline Beckman Corp |
3-benzazepines as alpha-2 antagonists
|
ZA827887B
(en)
|
1981-11-27 |
1983-11-30 |
Smithkline Beckman Corp |
Pharmaceutical compositions and method of producing alpha2 antagonism
|
FR2518544A1
(fr)
|
1981-12-22 |
1983-06-24 |
Lipha |
Benzodiazepines-1,3 thione-2, procede de preparation et medicament les contenant
|
FR2525603A1
(fr)
|
1982-04-27 |
1983-10-28 |
Adir |
Benzoazacycloalkyl-spiro-imidazolinines, leur preparation et leur application en therapeutique
|
US4988690A
(en)
|
1982-06-14 |
1991-01-29 |
Hoechst-Roussel Pharmaceuticals Inc. |
1-aryloxy-2,3,4,5-tetrahydro-3-benzazepines and anti-depressant use thereof
|
DE3418270A1
(de)
|
1984-05-17 |
1985-11-21 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
Neue aminotetralinderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
|
US4541954A
(en)
|
1984-09-05 |
1985-09-17 |
Smithkline Beckman Corporation |
Method for preparing 6-chloro-N-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine
|
EP0204349A3
(de)
|
1985-06-01 |
1990-01-03 |
Dr. Karl Thomae GmbH |
Neue heteroaromatische Aminderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
EG18188A
(en)
|
1986-05-01 |
1992-09-30 |
Pfizer Ltd |
Process for preparation anti-arhythmia agents
|
GB8610668D0
(en)
|
1986-05-01 |
1986-06-04 |
Pfizer Ltd |
Anti-arrhythmia agents
|
US4762845A
(en)
|
1986-05-21 |
1988-08-09 |
Abbott Laboratories |
7-(3-Substituted imino-1-pyrrolidinyl)-quinolone-3-carboxylic acids
|
EP0285287A3
(en)
|
1987-03-23 |
1990-08-16 |
Smithkline Beecham Corporation |
3-benzazepine compounds for use in treating gastrointestinal motility disorders
|
ZA882080B
(en)
|
1987-03-27 |
1989-04-26 |
Schering Corp |
Substituted benzazepines,their preparation and pharmaceutical compositions containing them
|
US5247080A
(en)
|
1987-03-27 |
1993-09-21 |
Schering Corporation |
Substituted benzazepines useful as intermediates for producing pharmaceutically active compounds
|
US5015639A
(en)
|
1987-03-27 |
1991-05-14 |
Schering Corporation |
Substituted benzazepines, their preparation and pharmaceutical compositions containing them
|
AU1700688A
(en)
|
1987-04-09 |
1988-11-04 |
Smithkline Beckman Corporation |
Sulfinyl and sulfonyl substituted 3-benzazepines
|
US4957914A
(en)
|
1987-05-15 |
1990-09-18 |
Syntex (U.S.A.) Inc. |
1,9-alkano-bridged-2,3,4,5-tetrahydro-1H-3-benzazepines
|
DK107688D0
(da)
|
1988-03-01 |
1988-03-01 |
Novo Industri As |
Carbaminsyreestere af substituerede 7-hydroxy-2,3,4,5-tetrahydro-1h-3-benzazepiner
|
US5422355A
(en)
|
1989-06-02 |
1995-06-06 |
John Wyeth & Brother, Limited |
Composition for treating depression with (N-heteroaryl)alkylamines
|
US5178786A
(en)
|
1989-08-04 |
1993-01-12 |
The Lubrizol Corporation |
Corrosion-inhibiting compositions and functional fluids containing same
|
MTP1076B
(en)
|
1990-01-12 |
1991-09-30 |
Ciba Geigy Ag |
Hemihydrate
|
WO1991011437A1
(en)
|
1990-02-02 |
1991-08-08 |
Schering Corporation |
4,5-cycloalkano-3-benzazepin-7-ol-derivatives and their use
|
CA2037162A1
(en)
|
1990-03-12 |
1991-09-13 |
Steven Howard Shaber |
Heterocyclicacetonitriles and fungicidal use
|
IL98487A0
(en)
|
1990-06-15 |
1992-07-15 |
Schering Corp |
8-lower alkyl-5-cycloalkyl or 5-cycloalkenyl substituted benzazepines and pharmaceutical compositions containing them
|
US5275915A
(en)
|
1991-06-05 |
1994-01-04 |
Dainippon Ink And Chemicals, Inc. |
Developer for light-sensitive material
|
JPH06508352A
(ja)
|
1991-06-21 |
1994-09-22 |
スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー |
門脈圧亢進症および片頭痛の治療用のテトラヒドロベンズアゼピン誘導体の使用
|
GB9116824D0
(en)
|
1991-08-05 |
1991-09-18 |
Smithkline Beecham Corp |
Chemical compounds
|
EP0558824A1
(en)
|
1992-02-04 |
1993-09-08 |
Duphar International Research B.V |
Method for the preparation of vicinal aminoalcohols and optically active O-protected derivatives thereof
|
US5241065A
(en)
|
1992-02-25 |
1993-08-31 |
Schering Corporation |
2,3,4,5-tetrahydro-1h-3-benzazepines having anti-psychotic activity
|
JPH05339263A
(ja)
|
1992-06-08 |
1993-12-21 |
Wakunaga Pharmaceut Co Ltd |
ジヒドロピリジン誘導体
|
JP2987258B2
(ja)
|
1992-07-13 |
1999-12-06 |
沖電気工業株式会社 |
非同期転送モード通信網におけるトラヒック監視方式
|
JPH06298746A
(ja)
|
1993-04-19 |
1994-10-25 |
Showa Denko Kk |
環状イミド酸エステルの製造法
|
AU7177694A
(en)
|
1993-06-23 |
1995-01-17 |
Cambridge Neuroscience, Inc. |
Sigma receptor ligands and the use thereof
|
US5387685A
(en)
|
1993-07-16 |
1995-02-07 |
American Cyanamid Co |
MDR reversal agents
|
GB9322976D0
(en)
|
1993-11-08 |
1994-01-05 |
Pfizer Ltd |
Therapeutic agents
|
DE4419247A1
(de)
|
1994-06-01 |
1995-12-07 |
Merckle Gmbh |
Sulfonylierte Pyrrolizincarbonsäureamide und deren Anwendung in der Pharmazie
|
DE4419246A1
(de)
|
1994-06-01 |
1995-12-07 |
Merckle Gmbh |
Heteroarylsubstituierte Pyrrolizinverbindungen und deren Anwendung in der Pharmazie
|
DE4419315A1
(de)
|
1994-06-01 |
1995-12-07 |
Merckle Gmbh |
Heteropyrrolizinverbindungen und deren Anwendung in der Pharmazie
|
DE4427838A1
(de)
|
1994-08-05 |
1996-02-08 |
Thomae Gmbh Dr K |
Kondensierte Azepinderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
DE4429079A1
(de)
|
1994-08-17 |
1996-02-22 |
Thomae Gmbh Dr K |
Cyclische Harnstoffderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
JPH08134048A
(ja)
|
1994-11-08 |
1996-05-28 |
Sumitomo Chem Co Ltd |
オキサゾリン類の製造法
|
DE19510566A1
(de)
|
1995-03-23 |
1996-09-26 |
Kali Chemie Pharma Gmbh |
Benzazepin-, Benzoxazepin- und Benzothiazepin-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
|
GB9508622D0
(en)
|
1995-04-28 |
1995-06-14 |
Pfizer Ltd |
Therapeutic agants
|
US5958543A
(en)
|
1995-07-07 |
1999-09-28 |
Stor Media,Inc. |
Micro-texturing for sputtered, thin film magnetic media disks utilizing titanium sputtered in the presence of hydrogen to form micro-texturing
|
JPH0930960A
(ja)
|
1995-07-18 |
1997-02-04 |
Takasago Internatl Corp |
真菌感染症治療剤
|
CA2190708A1
(en)
|
1995-12-08 |
1997-06-09 |
Johannes Aebi |
Aminoalkyl substituted benzo-heterocyclic compounds
|
US5892116A
(en)
|
1996-01-03 |
1999-04-06 |
Georgetown University |
Gelators
|
US5925651A
(en)
|
1996-04-03 |
1999-07-20 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
US5691362A
(en)
|
1996-06-05 |
1997-11-25 |
Schering-Plough Corporation |
Substituted benzene-fused hetero- and carbocyclics as nuerokinin antagonists
|
JP2001501172A
(ja)
|
1996-08-15 |
2001-01-30 |
スミスクライン・ビーチャム・コーポレイション |
Il―8レセプターアンタゴニスト
|
US5908830A
(en)
|
1996-10-31 |
1999-06-01 |
Merck & Co., Inc. |
Combination therapy for the treatment of diabetes and obesity
|
AU6290998A
(en)
|
1997-03-07 |
1998-09-29 |
Novo Nordisk A/S |
4,5,6,7-tetrahydro-thieno{3,2-c}pyridine derivatives, their preparation and use
|
AUPP020297A0
(en)
|
1997-11-05 |
1997-11-27 |
University Of Melbourne, The |
A novel receptor, and compounds which bind thereto
|
KR100620337B1
(ko)
|
1998-03-10 |
2006-09-13 |
오노 야꾸힝 고교 가부시키가이샤 |
카르복실산 유도체와 그 유도체를 유효 성분으로서함유하는 약제
|
JP3603177B2
(ja)
|
1998-03-26 |
2004-12-22 |
参天製薬株式会社 |
新規ウレア誘導体
|
US6492370B1
(en)
|
1998-03-26 |
2002-12-10 |
Santen Pharmaceutical Co., Ltd. |
Urea derivatives and pharmaceutical compositions thereof
|
EP0987235B1
(en)
|
1998-08-25 |
2003-03-12 |
MERCK PATENT GmbH |
Method for the conversion of arenes or alkenes with iodoalkenes, aryl iodides or arenediazonium salts
|
US20080103179A1
(en)
|
2006-10-27 |
2008-05-01 |
Tam Peter Y |
Combination Therapy
|
US20080255093A1
(en)
|
1999-06-14 |
2008-10-16 |
Tam Peter Y |
Compositions and methods for treating obesity and related disorders
|
EP1074549B1
(en)
|
1999-08-06 |
2003-11-19 |
F. Hoffmann-La Roche Ag |
Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors
|
ES2209728T3
(es)
|
1999-08-06 |
2004-07-01 |
F. Hoffmann-La Roche Ag |
Tetrahidro-benzo(d)azepinas y su uso como antagonistas de receptores de glutamato metabotropico.
|
JP2001076413A
(ja)
|
1999-09-06 |
2001-03-23 |
Sony Corp |
フレキシブル磁気ディスク用ヘッドスライダー
|
US6403657B1
(en)
|
1999-10-04 |
2002-06-11 |
Martin C. Hinz |
Comprehensive pharmacologic therapy for treatment of obesity
|
DE10003708A1
(de)
|
2000-01-28 |
2001-08-02 |
Solvent Innovation Gmbh |
Neuartige chirale ionische Flüssigkeiten und Verfahren zu ihrer Darstellung in enantiomerenreiner oder enantiomerenangereicherter Form
|
CN1305872C
(zh)
|
2000-06-30 |
2007-03-21 |
葛兰素集团有限公司 |
喹唑啉类化合物的制备方法
|
AR035369A1
(es)
|
2000-11-14 |
2004-05-12 |
Smithkline Beecham Plc |
Derivados de tetrahidrobenzazepina composiciones farmaceuticas que los comprenden, el uso de dichos derivados en la fabricacion de medicamentos, e intermediarios utiles en la preparacion de dichos compuestos
|
DE10057751A1
(de)
|
2000-11-22 |
2002-05-23 |
Bayer Ag |
Neue Carbamat-substituierte Pyrazolopyridinderivate
|
GB0030710D0
(en)
|
2000-12-15 |
2001-01-31 |
Hoffmann La Roche |
Piperazine derivatives
|
JPWO2002074746A1
(ja)
|
2001-03-16 |
2004-07-08 |
山之内製薬株式会社 |
ベンゾアゼピン誘導体
|
US6825198B2
(en)
|
2001-06-21 |
2004-11-30 |
Pfizer Inc |
5-HT receptor ligands and uses thereof
|
US7550261B2
(en)
|
2001-08-21 |
2009-06-23 |
Smithkline Beecham Corporation |
Method of screening for drug hypersensitivity reaction
|
EP1430032A2
(en)
|
2001-09-24 |
2004-06-23 |
Elan Pharmaceuticals, Inc. |
Substituted amides for the treatment of neurological disorders
|
WO2003062205A1
(en)
|
2001-12-21 |
2003-07-31 |
Smithkline Beecham P.L.C. |
7-sulfonyl-3-benzazepine derivatives as modulators of the dopamine receptor and their use for the treatment of cns disorders
|
WO2003057161A2
(en)
|
2001-12-28 |
2003-07-17 |
Bayer Pharmaceuticals Corporation |
BENZOTHIENO [3,2-c]PYRAZOLYL AND BENZOFURANO [3,2-c] PYRAZOLYL COMPOUNDS, THEIR USE IN DISEASES ASSOCIATED WITH THE 5-HT2C RECEPTOR AND INTERMEDIATE COMPOUNDS THEREOF
|
CA2473740A1
(en)
|
2002-01-18 |
2003-07-31 |
David Solow-Cordero |
Methods of treating conditions associated with an edg receptor
|
NZ534757A
(en)
|
2002-03-12 |
2006-07-28 |
Merck & Co Inc |
Substituted amides
|
US6953787B2
(en)
|
2002-04-12 |
2005-10-11 |
Arena Pharmaceuticals, Inc. |
5HT2C receptor modulators
|
CA2482195A1
(en)
|
2002-04-12 |
2003-10-23 |
The University Of Chicago |
Farnesoid x-activated receptor agonists
|
US7105505B2
(en)
|
2002-04-18 |
2006-09-12 |
Schering Corporation |
Benzimidazole derivatives useful as histamine H3 antagonists
|
DE10220570A1
(de)
|
2002-05-08 |
2003-11-20 |
Bayer Ag |
Carbamat-substituierte Pyrazolopyridine
|
GB0224557D0
(en)
|
2002-10-22 |
2002-11-27 |
Glaxo Group Ltd |
Novel compounds
|
DE10261131A1
(de)
|
2002-12-20 |
2004-07-01 |
Grünenthal GmbH |
Substituierte 5-Aminomethyl-1H-pyrrol-2-carbonsäureamide
|
US7145012B2
(en)
|
2003-04-23 |
2006-12-05 |
Pfizer Inc. |
Cannabinoid receptor ligands and uses thereof
|
US7232823B2
(en)
|
2003-06-09 |
2007-06-19 |
Pfizer, Inc. |
Cannabinoid receptor ligands and uses thereof
|
HUE028976T2
(en)
|
2003-06-17 |
2017-02-28 |
Arena Pharm Inc |
8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride
|
EA016558B1
(ru)
|
2003-06-17 |
2012-05-30 |
Арена Фармасьютикалз, Инк. |
Производные бензазепина, используемые для лечения заболеваний, ассоциированных с 5-ht-рецептором
|
MXPA05013365A
(es)
|
2003-06-20 |
2006-04-05 |
Arena Pharm Inc |
Derivados de n-fenil-piperazina y metodos para profilaxis o tratamiento de enfermedades asociadas con el receptor 5ht2c.
|
TW200510324A
(en)
|
2003-08-11 |
2005-03-16 |
Lilly Co Eli |
6-(2,2,2-trifluoroethylamino)-7-chiloro-2, 3, 4, 5-tetrahydro-1h-benzo[d]azepine as a 5-ht2c receptor agonist
|
WO2005042490A1
(en)
|
2003-10-22 |
2005-05-12 |
Arena Pharmaceuticals, Inc. |
Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases
|
US20080009478A1
(en)
|
2003-10-22 |
2008-01-10 |
Arena Pharmaceuticals, Inc. |
Benzazepine Derivatives and Methods of Prophylaxis or Treatment of 5Ht2c Receptor Associated Diseases
|
EA011011B1
(ru)
|
2004-02-25 |
2008-12-30 |
Эли Лилли Энд Компани |
6-ЗАМЕЩЁННЫЕ 2,3,4,5-ТЕТРАГИДРО-1H-БЕНЗО[d]АЗЕПИНЫ В КАЧЕСТВЕ АГОНИСТОВ РЕЦЕПТОРОВ 5-HT
|
US7157445B2
(en)
|
2004-02-26 |
2007-01-02 |
Aventis Pharma S.A. |
Administration of enoxaparin sodium to patients with severe renal impairment
|
SE0401871D0
(sv)
|
2004-07-15 |
2004-07-15 |
Glucogene Medical Hfm Ab |
New compositions
|
AU2005268781A1
(en)
|
2004-08-02 |
2006-02-09 |
Genmedica Therapeutics Sl |
Compounds for inhibiting copper-containing amine oxidases and uses thereof
|
US8178077B2
(en)
|
2004-10-19 |
2012-05-15 |
Reverse Proteomics Research Institute Co., Ltd. |
Drug development target protein and target gene, and method of screening
|
JP5270167B2
(ja)
|
2004-12-21 |
2013-08-21 |
アリーナ ファーマシューティカルズ, インコーポレイテッド |
(r)−8−クロロ−1−メチル−2,3,4,5−テトラヒドロ−1h−3−ベンザゼピン塩酸塩の結晶形
|
CN102631349A
(zh)
|
2004-12-23 |
2012-08-15 |
艾尼纳制药公司 |
5HT2c受体调节剂组合物和使用方法
|
JP5199997B2
(ja)
|
2006-04-03 |
2013-05-15 |
アリーナ ファーマシューティカルズ, インコーポレイテッド |
8−クロロ−1−メチル−2,3,4,5−テトラヒドロ−1h−3−ベンズアゼピンおよびこれに関連する中間体を調製するためのプロセス
|
CN101547892B
(zh)
*
|
2006-12-05 |
2014-08-20 |
艾尼纳制药公司 |
制备(r)-8-氯-1-甲基-2,3,4,5-四氢-1h-3-苯并氮杂卓的方法和其中间体
|
JP5513378B2
(ja)
|
2007-06-15 |
2014-06-04 |
ユニバーシティ オブ フロリダ リサーチ ファウンデーション,インコーポレイテッド |
治療化合物
|
WO2009080691A2
(en)
|
2007-12-20 |
2009-07-02 |
Neurosearch A/S |
Pharmaceutical composition comprising tesofensine or its analogue and an anti-obesity compound
|
WO2009097416A1
(en)
|
2008-01-29 |
2009-08-06 |
Vanda Pharmaceuticals, Inc. |
Imidazolylalkyl- pyridines as dbh inhibitors
|
JP5491421B2
(ja)
|
2008-03-04 |
2014-05-14 |
アリーナ ファーマシューティカルズ, インコーポレイテッド |
5−ht2cアゴニストである(r)−8−クロロ−1−メチル−2,3,4,5−テトラヒドロ−1h−3−ベンゾアゼピンに関連する中間体の調製のためのプロセス
|
US7608616B1
(en)
|
2008-06-03 |
2009-10-27 |
Questcor Pharmaceuticals, Inc. |
Methods for reducing the risk of an adverse drug interaction in a patient suffering from insomnia
|
WO2010148207A2
(en)
|
2009-06-18 |
2010-12-23 |
Arena Pharmaceuticals, Inc. |
Processes for the preparation of 5-ht2c receptor agonists
|
US8999970B2
(en)
|
2010-09-01 |
2015-04-07 |
Arena Pharmaceuticals, Inc. |
Administration of an anti-obesity compound to individuals with renal impairment
|
JP2013536858A
(ja)
|
2010-09-01 |
2013-09-26 |
アリーナ ファーマシューティカルズ, インコーポレイテッド |
5−ht2cアゴニストの速く溶解する剤形
|
SG10201506870PA
(en)
|
2010-09-01 |
2015-10-29 |
Arena Pharm Inc |
Salts of lorcaserin with optically active acids
|
WO2012030953A1
(en)
|
2010-09-01 |
2012-03-08 |
Arena Pharmaceuticals, Inc. |
5-ht2c receptor agonists in the treatment of disorders ameliorated by reduction of norepinephrine level
|
SG188362A1
(en)
|
2010-09-01 |
2013-04-30 |
Arena Pharm Inc |
Modified-release dosage forms of 5-ht2c agonists useful for weight management
|
CN102126988A
(zh)
|
2010-12-17 |
2011-07-20 |
张家港瀚康化工有限公司 |
4-(4-氯苯基)-2-溴甲基-2-苯基丁腈的制备方法
|